Description:

Neuroprotection With Phenytoin in Optic Neuritis; ODM derived from: https://clinicaltrials.gov/show/NCT01451593

Link:

https://clinicaltrials.gov/show/NCT01451593

Keywords:
Versions (3) ▾
  1. 1/21/21
  2. 1/21/21
  3. 1/22/21
Copyright Holder:
University College, London
Uploaded on:

January 22, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Optic Neuritis NCT01451593

Eligibility Optic Neuritis NCT01451593

Inclusion Criteria
diagnosis of acute optic neuritis
visual acuity in affected eye ≤ 6/12
corrected vision in normal eye ≥ 6/6
no history of optic neuritis or other ocular disease in either eye
≤ 14 days since onset of visual loss
Exclusion Criteria
contraindication or known allergy to phenytoin
contraindication to mri
use of a calcium channel or sodium channel blocker in the past 2 months
corticosteroid use in the past 2 months
tysabri infusion in the past 3 months
ms with major temperature dependent disability
relapsing remitting ms of greater than 10 yrs duration or edss>3
pregnancy
breast feeding
significant cardiac, renal or liver abnormalities